Oncolin Therapeutics, Inc. Provides a Company Overview
3/25/2008 8:38:44 AM
More...
|
Edgeline Holdings to Add Industry Veteran to Its Scientific Advisory Board
3/7/2008 9:01:12 AM
More...
|
Edgeline Holdings Agrees to Terms for an Exclusive Worldwide Right to Option Patents Covering the Composition and Use of Genistein Analogs for Cancer Treatment
2/27/2008 9:06:25 AM
More...
|
Edgeline Holdings Announces an Agreement that Provides Enabling Technology for Its Lead Clinical Program
2/20/2008 9:03:08 AM
More...
|
Edgeline Holdings Announces a Strategic Business Change to Focus Exclusively on Biotechnology and is Changing Its Name to Oncolin Therapeutics, Inc.
2/12/2008 9:34:03 AM
More...
|
Edgeline Holdings Signs Joint Development Agreement with Houston Pharmaceuticals
12/11/2007 2:08:00 PM
More...
|
Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed
12/4/2007 11:06:06 AM
More...
|
Edgeline Holdings to Close on Its Acquisition of Intertech Bio
10/16/2007 11:32:20 AM
More...
|